Ping An Biomedical Enters into Patent Purchase Agreement with Future Biotechnology Group for Tumor Cell Technologies
Ping An Biomedical Co., Ltd. (NASDAQ:PASW) (the "Company") today announced that it has entered into a definitive purchase agreement (the "Agreement") with Future Biotechnology Group Co., Limited for the acquisition (the "Acquisition") of three tumor cell-related medical technology patents covering areas including oncology diagnosis and treatment, cell detection and bioengineering, and biomarker and DNA probe technologies, for a consideration of US$2.3 million. The Agreement follows the Company’s previously announced letter of intent dated October 22, 2026. The Acquisition is intended to support the Company’s longer-term healthcare and biomedical